publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. The majority of clinical trials used products standardized to 4 or 5 mg andrographolide per tablet. A reasonable dose regimen would be two to four of these tablets, three times daily, for the first few days of a cold. There are no known side effects of andrographolide; however, as with all medicinal treatments, caution and careful use are recommended. 